Industries > Pharma > Preclinical CRO Market Report 2020-2030

Back to Pharma Reports

Preclinical CRO Market Report 2020-2030

Forecasts by Services (Bioanalysis & DMPK Studies, Toxicology Testing), by End-use (Biopharmaceutical Companies, Medical Device Companies), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies

PAGES: 158

PRODUCT CODE: PHA0804

SUBMARKET: Drug Discovery Development & Production

DOWNLOAD FREE SAMPLE

Licence

Clear

DOWNLOAD FREE SAMPLE

SKU: PHA0804 Categories: Drug Discovery Development & Production, Pharma Tags: PHA0804, PHA1133

Preclinical CRO Market-our new study reveals trends, R&D progress, and predicted revenues
Where the Preclinical CRO market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 80+ tables, 30+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Preclinical CRO market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Report Scope
Global Preclinical CRO market 2020-2030 is segmented on the basis of Services, End Use, and geography.

• Revenue and growth forecasts from 2020 to 2030 for the Global Preclinical CRO Market by Services:
– Bioanalysis & DMPK Studies
– Toxicology Testing

• Revenue and growth forecasts from 2020 to 2030 for the Global Preclinical CRO Market by End Use:
– Biopharmaceutical Companies
– Medical Device Companies

• Revenue and growth forecasts from 2020 to 2030 for the Global Preclinical CRO Market by Region:
– North America: US, Canada
– Europe: Germany, UK, Italy, France, Spain, Rest of Europe
– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific
– Latin America: Brazil, Mexico, and Rest of Latin America
– Middle East & Africa: GCC, South Africa, Rest of LAMEA

• Our study discusses the selected leading companies that are the major players in the Preclinical CRO industry:
– Envigo Corporation
– MPI research
– Eurofins Scientific
– PRA Health Sciences, Inc.
– Wuxi AppTec
– Medpace, Inc.
– Pharmaceutical Product Development, LLC
– Paraxel International Corporation
– Icon Plc
– Laboratory Corporation of America, Inc.

How the Preclinical CRO Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2030 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.
– Revenue forecasts to 2030 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Preclinical CRO market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Preclinical CRO market and leading companies. You will find data, trends and predictions.

The Preclinical CRO Market 2020-2030 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Preclinical CRO industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Preclinical CRO Market Report 2020-2030: Forecasts by Services (Bioanalysis & DMPK Studies, Toxicology Testing), by End-use (Biopharmaceutical Companies, Medical Device Companies), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1. Market Definition

1.2. Why Should You Read This Report?

1.3. How This Report Delivers?

1.4. Key Questions Answered by This Analytical Report:

1.5. Who is this Report for?

1.6. Research Methodology

1.7. Frequently Asked Questions (FAQ)

1.8. About Visiongain

2. Introduction To The Preclinical CRO Market

2.1. What are Preclinical CRO Servicess?

2.2. Global Preclinical CRO Market Segmentation

2.3. Assumptions For The Study

3. Qualitative Analysis of the Global Preclinical CRO Market

3.1. SWOT Analysis of The Global Preclinical CRO Market

3.2. PESTLE Analysis

3.3. Market Trends

3.4. Drivers

3.4.1. Increase in number of drugs undergoing preclinical phase

3.4.2. Rise in R&D investment and expenditure

3.4.3. Growing demand for outsourcing services

3.5. Restraints

3.5.1. High labor costs

3.5.2. Stringent regulatory policies

3.6. Opportunity

3.6.1. Technological advancement

4. Global Preclinical CRO Market, by Services, 2020-2030

4.1. Global Preclinical CRO Market Forecast, 2020-2030

4.2. Bioanalysis & DMPK Studies

4.2.1. Preclinical CRO Market for Bioanalysis & DMPK Studies by Region: Market Forecasts 2020-2030

4.3. Toxicology Testing

4.3.1. Preclinical CRO Market for Toxicology Testing by Region: Market Forecasts 2020-2030

5. Global Preclinical CRO Market, by End User, 2020-2030

5.1. Global Preclinical CRO Market Forecast, 2020-2030

5.2. Biopharmaceutical Companies

5.2.1. Preclinical CRO Market for Biopharmaceutical Companies by Region: Market Forecasts 2020-2030

5.3. Medical Device Companies

5.3.1. Preclinical CRO Market for Medical Device Companies by Region: Market Forecasts 2020-2030

6. Leading National Markets Forecast 2020-2030

6.1. Geographical Breakdown of Global Preclinical CRO Market, 2019

7. North America Preclinical CRO Market, 2020-2030

7.1. U.S. Preclinical CRO Market Forecast, 2020-2030

7.2. U.S Preclinical CRO Market, Trends and Developments

7.3. Canada Preclinical CRO Market Forecast, 2020-2030

7.4. Canada Preclinical CRO Market, Trends and Developments

8. Europe Preclinical CRO Market, 2020-2030

8.1. Germany Preclinical CRO Market Forecast, 2020-2030

8.2. Germany Preclinical CRO Market, Trends and Developments

8.3. France Preclinical CRO Market Forecast, 2020-2030

8.4. France Preclinical CRO Market, Trends and Developments

8.5. UK Preclinical CRO Market Forecast, 2020-2030

8.6. UK Preclinical CRO Market, Trends and Developments

8.7. Italy Preclinical CRO Market Forecast, 2020-2030

8.8. Italy Preclinical CRO Market, Trends and Developments

8.9. Spain Preclinical CRO Market Forecast, 2020-2030

8.10. Spain Preclinical CRO Market, Trends and Developments

8.11. Rest of Europe Preclinical CRO Market Forecast, 2020-2030

8.12. Rest of Europe Preclinical CRO Market, Trends and Developments

9. Asia Pacific Preclinical CRO Market, 2020-2030

9.1. Japan Preclinical CRO Market Forecast, 2020-2030

9.2. Japan Preclinical CRO Market, Trends and Developments

9.3. China Preclinical CRO Market Forecast, 2020-2030

9.4. China Preclinical CRO Market, Trends and Developments

9.5. India Preclinical CRO Market Forecast, 2020-2030

9.6. India Preclinical CRO Market, Trends and Developments

9.7. Australia Preclinical CRO Market Forecast, 2020-2030

9.8. Australia Preclinical CRO Market, Trends and Developments

9.9. Rest of APAC Preclinical CRO Market Forecast, 2020-2030

9.10. Rest of APAC Preclinical CRO Market, Trends and Developments

10. Latin America Preclinical CRO Market, 2020-2030

10.1. Brazil Preclinical CRO Market Forecast, 2020-2030

10.2. Brazil Preclinical CRO Market, Trends and Developments

10.3. Mexico Preclinical CRO Market Forecast, 2020-2030

10.4. Mexico Preclinical CRO Market, Trends and Developments

10.5. Rest of Latin America Preclinical CRO Market Forecast, 2020-2030

10.6. Rest of Latin America Preclinical CRO Market, Trends and Developments

11. MEA Preclinical CRO Market, 2020-2030

11.1. GCC Countries Preclinical CRO Market Forecast, 2020-2030

11.2. GCC Countries Preclinical CRO Market, Trends and Developments

11.3. South Africa Preclinical CRO Market Forecast, 2020-2030

11.4. South Africa Preclinical CRO Market, Trends and Developments

11.5. Rest of MEA Preclinical CRO Market Forecast, 2020-2030

11.6. Rest of MEA Preclinical CRO Market, Trends and Developments

12. Leading Preclinical CRO Companies

12.1. Envigo Corporation

12.1.1. Company Overview

12.1.2. Product Portfolio

12.1.3. Sales Analysis

12.2. MPI research

12.2.1. Company Overview

12.2.2. Product Portfolio

12.2.3. Sales Analysis

12.3. Eurofins Scientific

12.3.1. Company Overview

12.3.2. Product Portfolio

12.3.3. Sales Analysis

12.4. PRA Health Sciences, Inc.

12.4.1. Company Overview

12.4.2. Product Portfolio

12.4.3. Sales Analysis

12.5. Wuxi AppTec

12.5.1. Company Overview

12.5.2. Product Portfolio

12.5.3. Sales Analysis

12.6. Medpace, Inc.

12.6.1. Company Overview

12.6.2. Product Portfolio

12.6.3. Sales Analysis

12.7. Pharmaceutical Product Development, LLC

12.7.1. Company Overview

12.7.2. Product Portfolio

12.7.3. Sales Analysis

12.8. Paraxel International Corporation

12.8.1. Company Overview

12.8.2. Product Portfolio

12.8.3. Sales Analysis

12.9. Icon Plc

12.9.1. Company Overview

12.9.2. Product Portfolio

12.9.3. Sales Analysis

12.10. Laboratory Corporation of America, Inc.

12.10.1. Company Overview

12.10.2. Product Portfolio

12.10.3. Sales Analysis

13. Conclusion & Recommendations

14. Glossary

14.1. Associated Visiongain Reports

14.2. Visiongain Report Sales Order Form

14.3. About Visiongain

14.4. Visiongain report evaluation form

List of Tables

Table 4.1. Global Preclinical CRO Market, by Services, Forecast ($Mn, AGR%), 2020-2030

Table 4.2. Global Preclinical CRO Market for Bioanalysis & DMPK Studies, by Region, Forecast ($Mn, AGR%), 2020-2030

Table 4.3. Global Preclinical CRO Market for Toxicology Testing, by Region, Forecast ($Mn, AGR%), 2020-2030

Table 5.1. Global Preclinical CRO Market, by End User, Forecast ($Mn, AGR%), 2020-2030

Table 5.2. Global Preclinical CRO Market for Biopharmaceutical Companies, by Region, Forecast ($Mn, AGR%), 2020-2030

Table 5.3. Global Preclinical CRO Market for Medical Device Companies, by Region, Forecast ($Mn, AGR%), 2020-2030

Table 7.1 North American Preclinical CRO Market Forecast, by Country, 2020-2030 ($Mn, AGR%)

Table 7.2 North American Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 7.3 North American Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 7.4 US Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 7.5 US Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 7.6 Canada Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 7.7 Canada Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.1 Europe Preclinical CRO Market Forecast, by Country, 2020-2030 ($Mn, AGR%)

Table 8.2 Europe Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.3 Europe Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.4 Germany Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.5 Germany Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.6 France Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.7 France Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.8 UK Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.9 UK Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.10 Spain Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.11 Spain Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.12 Italy Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.13 Italy Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 8.14 Rest of Europe Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 8.15 Rest of Europe Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.1 Asia-Pacific Preclinical CRO Market Forecast, by Country, 2020-2030 ($Mn, AGR%)

Table 9.2 Asia-Pacific Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.3 Asia-Pacific Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.4 China Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.5 China Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.6 Japan Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.7 Japan Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.8 India Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.9 India Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.10 Australia Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.11 Australia Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 9.12 Rest of Asia-Pacific Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 9.13 Rest of Asia-Pacific Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 12.1 Latin America Preclinical CRO Market Forecast, by Country, 2020-2030 ($Mn, AGR%)

Table 12.2 Latin America Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 12.3 Latin America Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 12.4 Brazil Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 12.5 Brazil Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 12.6 Mexico Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 12.7 Mexico Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 12.8 Rest of Latin America Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 12.9 Rest of Latin America Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 11.1 Middle East & Africa Preclinical CRO Market Forecast, by Country, 2020-2030 ($Mn, AGR%)

Table 11.2 Middle East & Africa Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 11.3 Middle East & Africa Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 11.4 GCC Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 11.5 GCC Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 11.6 South Africa Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 11.7 South Africa Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 11.8 Rest of Middle East & Africa Preclinical CRO Market Forecast, by Services, 2020-2030 ($Mn, AGR%)

Table 11.9 Rest of Middle East & Africa Preclinical CRO Market Forecast, by End User, ($Mn, AGR%), 2020-2030

Table 12.1 Envigo Corporation Product Portfolio

Table 12.2 MPI research Product Portfolio

Table 12.3 Eurofins Scientific Product Portfolio

Table 12.4 PRA Health Sciences, Inc. Product Portfolio

Table 12.5 Wuxi AppTec Product Portfolio

Table 12.6 Medpace, Inc. Product Portfolio

Table 12.7 Pharmaceutical Product Development, LLC Product Portfolio

Table 12.8 Paraxel International Corporation Product Portfolio

Table 12.9 Icon Plc Product Portfolio

Table 12.10 Laboratory Corporation of America, Inc. Product Portfolio

List of Figures

Figure 4.1. Global Preclinical CRO Market, by Services, Forecast ($Mn) 2020-2030

Figure 5.1. Global Preclinical CRO Market, by End User, Forecast ($Mn) 2020-2030

Figure 6.1. Global Preclinical CRO Market, by Region, Forecast ($Mn), 2020-2030

Figure 7.1 North American Preclinical CRO Market Forecast, ($Mn), 2020-2030

Figure 8.1 Europe Preclinical CRO Market Forecast, ($Mn), 2020-2030

Figure 9.1 Asia-Pacific Preclinical CRO Market Forecast, ($Mn), 2020-2030

Figure 12.1 Latin America Preclinical CRO Market Forecast, ($Mn), 2020-2030

Figure 11.1 Middle East & Africa Preclinical CRO Market Forecast, ($Mn), 2020-2030

Figure 12.1 Envigo Corporation Sales Analysis ($Mn)

Figure 12.2 MPI research Sales Analysis ($Mn)

Figure 12.3 Eurofins Scientific Sales Analysis ($Mn)

Figure 12.4 PRA Health Sciences, Inc. Sales Analysis ($Mn)

Figure 12.5 Wuxi AppTec Sales Analysis ($Mn)

Figure 12.6 Medpace, Inc. Sales Analysis ($Mn)

Figure 12.7 Pharmaceutical Product Development, LLC Sales Analysis ($Mn)

Figure 12.8 Paraxel International Corporation Sales Analysis ($Mn)

Figure 12.9 Icon Plc Sales Analysis ($Mn)

Figure 12.10 Laboratory Corporation of America, Inc. Sales Analysis ($Mn)

Absorption Systems

ACEA Biosciences, Inc.

Advantar Laboratories

Advinus

Agilent Technologies

Aginko Research

AIT Bioscience

Alliance Pharma

American Preclinical Servi

Atlantic Bone Screen

ATS Labs Minnesota

Aviva Biosciences

Axiogenesis AG

Baltic Clinical Research

BASi

Battelle

BD Biosciences

Beaufort

Bio-Boston Contract Laborator

BioAgilytix Labs

BIOCIUS Life Sciences

Bioduro

Bioneeds Preclinical Services

BioReliance Corporation

Blue Sky BioServices

Blue Stream Laboratories

Bristol-Myers Squibb

Calvert Laboratories, Inc.

CeeTox, Inc.

Celsis

Cenix BioScience

CERB

ChanTest

Charles River

Charles River Laboratories

CirQuest Labs

CiTox

Comac Medical

Comparative Ophthalmic Resear

Contract Assay Services

CorDynamics

Corealis Pharma Inc.

Covance

CTI

Dabur Research Foundation

DaVinci Biomedical Research P

Envigo Corporation

Eurofins (Cerep & Panlabs Mer

Eurofins Scientific

Experimental Pathology Labora

Flow Contract Site Laboratory

Fluofarma

Frontier BioSciences

Gateway Pharmacology Laborato

Gerson Pharma Solutions, LLC

Histo-Scientific Research Lab

Huntingdon Life Sciences

Icon Plc

IITRI Research Institute

InterVivo Solutions

IonsGate Preclinical Services

IPS Therapeutics

IQVIA

Iris Pharma

ISIS Pharmaceuticals

ITR Canada

KARD Scientific

Laboratory Corporation of America, Inc.

Leadscope

Litron Laboratories

Lonza

Lovelace Respiratory Research

Marin Biologic Laboratories

MB Research

MD Biosciences

Medpace, Inc.

Millar Instruments

Monell Center

MPI Research

NDA Analytics

Neuro Service

North American Science Associ

NOTOCORD

OUTPUT Pharma Services GmbH

Pacific BioLabs

PAIRimmune Inc.

Paraxel International Corporation

Particle Sciences Inc.

Patheon

PCI Pharma

PDS Preclinical Data Systems,

PerkinElmer

Perry Scientific, Inc.Pharmaron

Pharmaceutical Product Development, LLC

PharmOptima

PhysioGenix, Inc.

Porsolt

PRA Health Sciences, Inc.

PreLabs, LLC

Premier Laboratory, LLC

Prolynx LLC

Psychogenics

Reaction Biology Corp.

Retrievex

Ricerca Biosciences LLC

S P Software Technologies

SABiosciences

Sartorius Stedim Services

Sensory Spectrum

Seventh Wave

Sinclair Research

Sirius Analytical

Smithers Avanza

Solutions OP LTD

Southern Research

SRI

Stillmeadow

Suven Life Sciences Limited

Syngene International Ltd.

SynteractHCR

Toxikon Corporation

TransPharm Preclinical Solutions LLC

University of Mississippi Medical Research

Velesco Pharmaceutical Services

Vet Path Services, Inc.

Vimta Labs

Wake Forest Innovations

West Pharmaceutical Services

Wil Research

William Harvey Research Limited

Wolfe labs

WuXi AppTec, Inc.

Xenometrics

XenoTech

Download sample pages

Complete the form below to download your free sample pages for Preclinical CRO Market Report 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Preclinical CRO Market Report 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

READ

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

READ

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

READ

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

READ

Industries > Pharma > Preclinical CRO Market Report 2020-2030

Back to Pharma Reports

Preclinical CRO Market Report 2020-2030

Download sample pages

Related reports

Enteric Soft Gel Capsules Market Report 2021-2031

Cell-Based Assays Market Report to 2030

Aortic Aneurysm Market Report 2021-2031

Antibody Drug Conjugates Market Report 2021-2031

Therapeutic Respiratory Devices Market Report 2021-2031

Cancer Diagnostics Market Report 2021-2031

Antibiotics Market Report 2021-2031

Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Antiviral Drugs Treatment Market Report 2021-2031

Anti-Infective Agents Market Report 2021-2031

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

Our Clients